Skip to Main Content

Paper Details

Pharmacogenomic study of heart failure and candesartan response from the CHARM programme.
ESC Heart Fail
2
2022
8p21, A allele, Candesartan, HF, Heart failure, angiotensin-converting enzyme, candesartan, cardiovascular, gene, genetic variant, heart failure, hyperkalaemia, hypotension, patients, renal dysfunction, rs66886237
Author NameAffiliation
Dirk S Paul
Salim YusufThe Population Health Research Institute, McMaster University
Jean-Claude TardifMontreal Heart Institute
Jean-Claude TardifUniversite de Montreal
  • 1 - 4

Datasets

Release 1.2